Oppenheimer Downgrades Crescent Capital BDC to Perform, Lowers Price Target to $16

Benzinga Newsdesk www.benzinga.com Negative 91.6%

Neg 91.6% Neu 0% Pos 0%

Oppenheimer analyst Mitchel Penn downgrades Crescent Capital BDC (NASDAQ:CCAP) from Outperform to Perform and lowers the price target from $19 to $16.